Cargando…

S144: BTK AND BCL-2 ACTIVITY AT BASELINE PREDICTS MRD STATUS FOR CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS TREATED WITH IBRUTINIB + VENETOCLAX IN THE HOVON 141/VISION TRIAL

Detalles Bibliográficos
Autores principales:	Urban, Aleksandra, Hermansen, Johanne, Yin, Yanping, Kong, Weikaixin, Teglgaard, Rebecca, Brieghel, Christian, Kersting, Sabina, Tjønnfjord, Geir E., Levin, Mark-David, Tran, Hoa T. T., Mattsson, Mattias, Ranti, Juha, Veldhuis, Gerrit-Jan, Da Cunha-Bang, Caspar, Mous, Rogier, Dubois, Julie, Kater, Arnon, Niemann, Carsten, Aittokallio, Tero, Skånland, Sigrid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Oral Sessions
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428272/ http://dx.doi.org/10.1097/01.HS9.0000967488.92046.ec

Ejemplares similares